Genetic evaluations have identified four clinically significant mutations: NCOR1, PIK3CA, U2AF1, and PLXNA1. The expression of NCOR1 may influence how cervical cancer cells metastasize to the spleen. This evidence concerns the gene U2AF1 and cervical cancer.